risks detailed in Part II, Item 1A titled “Risk Factors” and in the other reports the Company has filed with the Securities and Exchange Commission (“SEC’). Additionally, refer to COVID-19 earlier in this Management’s Discussion and Analysis.
The full impact of the COVID-19 pandemic on our rental revenue and, as a result, future cash from operations cannot be determined at present.
Capitalization
As of June 30, 2020, the Company’s total market capitalization was approximately $4.3 billion. Total market capitalization consisted of $3.6 billion of common equity (based on the June 30, 2020 closing price on the NYSE of $65.71 per common share and assuming the conversion of Operating Partnership Units and $747.5 million of total debt, including (i) zero borrowings under its revolving credit facility; (ii) $240.0 million of unsecured term loans; (iii) $510.0 million of senior unsecured notes; (iv) $33.9 million of mortgage notes payable, less (v) cash, cash equivalents and cash held in escrow of $36.4 million. The Company’s ratio of total debt to total market capitalization was 18.2% at June 30, 2020.
At June 30, 2020, the non-controlling interest in the Operating Partnership represented ownership of 0.6% of the Operating Partnership. The Operating Partnership Units may, under certain circumstances, be exchanged for shares of common stock on a one-for-one basis. The Company, as sole general partner of the Operating Partnership, has the option to settle exchanged Operating Partnership Units held by others for cash based on the current trading price of its shares. Assuming the exchange of all Operating Partnership Units, there would have been 54,198,711 shares of common stock outstanding at June 30, 2020.
Equity
Follow-on Public Offerings
In September 2018, the Company entered into a follow-on public offering of 3,500,000 shares of common stock in connection with a forward sale agreement (the “September 2018 Forward”). The September 2018 Forward was settled in its entirety in April 2019. Upon settlement, the Company issued 3,500,000 shares of common stock and received net proceeds of $186.0 million, after deducting fees and expenses.
In April 2019, the Company entered into a follow-on public offering (the “April 2019 Forward) to sell an aggregate of 3,162,500 shares of common stock, which included the full exercise of the underwriters’ option to purchase an additional 412,500 shares of common stock. The April 2019 Forward was settled in its entirety in December 2019. Upon settlement, the Company issued 3,162,500 shares of common stock and received net proceeds of approximately $195.8 million, after deducting fees and expenses.
In April 2020, the Company completed a follow-on public offering of 2,875,000 shares of common stock, which included the full exercise of the underwriters’ option to purchase an additional 375,000 shares of common stock. Upon closing the Company issued 2,875,000 shares and received net proceeds of $170.4 million, after deducting fees and expenses.
Also in April 2020, the Company entered into a follow-on public offering (the “April 2020 Forward”) to sell an aggregate of 6,166,666 shares of common stock in connection with a forward sale agreement. As of June 30, 2020, the Company has not received proceeds from the sale of shares of its common stock by the forward purchaser. The April 2020 Forward is required to be settled no later than April 20, 2021.
2019 ATM Program
In July 2019, the Company entered into a $400.0 million at-the-market equity (“ATM”) program (the “2019 ATM Program”) through which the Company, from time to time, sold shares of common stock. During the third quarter of 2019, the Company issued 444,228 shares of common stock under the 2019 ATM Program, at an average price of $74.30, realizing gross proceeds of $33.0 million. In addition to selling shares of common stock, the Company also entered into forward sale agreements through the 2019 ATM Program, as described below.